Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2791629423', 'doi': 'https://doi.org/10.1002/cpdd.428', 'title': 'Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia', 'display_name': 'Pharmacokinetics and Safety of Risperidone Subcutaneous Implants in Stable Patients With Schizophrenia', 'publication_year': 2018, 'publication_date': '2018-02-08', 'ids': {'openalex': 'https://openalex.org/W2791629423', 'doi': 'https://doi.org/10.1002/cpdd.428', 'mag': '2791629423', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/29420868'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/cpdd.428', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5050173886', 'display_name': 'Ryan Dammerman', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1320553840', 'display_name': 'Amgen (United States)', 'ror': 'https://ror.org/03g03ge92', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I1320553840']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ryan Dammerman', 'raw_affiliation_strings': ['Braeburn Pharmaceuticals, Princeton, NJ, USA', 'Present address: Amgen Inc., Thousand Oaks, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Braeburn Pharmaceuticals, Princeton, NJ, USA', 'institution_ids': []}, {'raw_affiliation_string': 'Present address: Amgen Inc., Thousand Oaks, CA, USA', 'institution_ids': ['https://openalex.org/I1320553840']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5086750815', 'display_name': 'Sonnie Kim', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'Sonnie Kim', 'raw_affiliation_strings': ['Braeburn Pharmaceuticals, Princeton, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Braeburn Pharmaceuticals, Princeton, NJ, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5018463564', 'display_name': 'Mathews Adera', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mathews Adera', 'raw_affiliation_strings': ['Braeburn Pharmaceuticals, Princeton, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Braeburn Pharmaceuticals, Princeton, NJ, USA', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5061508735', 'display_name': 'Alex Schwarz', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alex Schwarz', 'raw_affiliation_strings': ['Braeburn Pharmaceuticals, Princeton, NJ, USA'], 'affiliations': [{'raw_affiliation_string': 'Braeburn Pharmaceuticals, Princeton, NJ, USA', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5086750815'], 'corresponding_institution_ids': [], 'apc_list': {'value': 3450, 'currency': 'USD', 'value_usd': 3450, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 2.733, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 21, 'citation_normalized_percentile': {'value': 0.856061, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 91, 'max': 92}, 'biblio': {'volume': '7', 'issue': '3', 'first_page': '298', 'last_page': '310'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10854', 'display_name': 'Bipolar Disorder and Treatment', 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10056', 'display_name': 'Neurotransmitter Receptor Influence on Behavior', 'score': 0.9901, 'subfield': {'id': 'https://openalex.org/subfields/2804', 'display_name': 'Cellular and Molecular Neuroscience'}, 'field': {'id': 'https://openalex.org/fields/28', 'display_name': 'Neuroscience'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.9388908}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.83975774}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.7664813}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.6353623}, {'id': 'https://openalex.org/C3020079912', 'wikidata': 'https://www.wikidata.org/wiki/Q3918988', 'display_name': 'Plasma concentration', 'level': 2, 'score': 0.43365306}, {'id': 'https://openalex.org/C2777056448', 'wikidata': 'https://www.wikidata.org/wiki/Q285166', 'display_name': 'Oral administration', 'level': 2, 'score': 0.41790795}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.3983763}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.3470006}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.2074525}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': True}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D065566', 'descriptor_name': 'Subcutaneous Absorption', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003692', 'descriptor_name': 'Delayed-Action Preparations', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D065566', 'descriptor_name': 'Subcutaneous Absorption', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D065566', 'descriptor_name': 'Subcutaneous Absorption', 'qualifier_ui': 'Q000502', 'qualifier_name': 'physiology', 'is_major_topic': False}, {'descriptor_ui': 'D055815', 'descriptor_name': 'Young Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1002/cpdd.428', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764863641', 'display_name': 'Clinical Pharmacology in Drug Development', 'issn_l': '2160-763X', 'issn': ['2160-763X', '2160-7648'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/29420868', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.79}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 37, 'referenced_works': ['https://openalex.org/W153750880', 'https://openalex.org/W1596948422', 'https://openalex.org/W1598068766', 'https://openalex.org/W1964688493', 'https://openalex.org/W1969486406', 'https://openalex.org/W1972852190', 'https://openalex.org/W1973562905', 'https://openalex.org/W1986349579', 'https://openalex.org/W1994266556', 'https://openalex.org/W1994627117', 'https://openalex.org/W2005630045', 'https://openalex.org/W2019087919', 'https://openalex.org/W2020615571', 'https://openalex.org/W2025820352', 'https://openalex.org/W2034177343', 'https://openalex.org/W2036441297', 'https://openalex.org/W2047241207', 'https://openalex.org/W2053705303', 'https://openalex.org/W2058415836', 'https://openalex.org/W2077006703', 'https://openalex.org/W2078169913', 'https://openalex.org/W2081662762', 'https://openalex.org/W2091660180', 'https://openalex.org/W2096710308', 'https://openalex.org/W2104175708', 'https://openalex.org/W2107962758', 'https://openalex.org/W2139645720', 'https://openalex.org/W2140000974', 'https://openalex.org/W2143267960', 'https://openalex.org/W2148228045', 'https://openalex.org/W2157408003', 'https://openalex.org/W2159726386', 'https://openalex.org/W2168686681', 'https://openalex.org/W2172236423', 'https://openalex.org/W2269711101', 'https://openalex.org/W2292125616', 'https://openalex.org/W2327880444'], 'related_works': ['https://openalex.org/W2472211910', 'https://openalex.org/W2431352314', 'https://openalex.org/W2414263157', 'https://openalex.org/W2331297863', 'https://openalex.org/W2317627837', 'https://openalex.org/W2090901580', 'https://openalex.org/W2001333918', 'https://openalex.org/W1972661330', 'https://openalex.org/W1964074490', 'https://openalex.org/W1573667742'], 'abstract_inverted_index': {'A': [0], 'subcutaneous': [1], 'risperidone': [2, 74, 116], 'implant': [3], '(RI)': [4], 'formulation': [5, 193], 'was': [6, 145, 167], 'developed': [7], 'to': [8, 20, 169], 'improve': [9], 'medication': [10], 'adherence': [11], 'in': [12, 26, 110], 'schizophrenia.': [13, 30], 'Two': [14], 'phase': [15], '1': [16, 52], 'studies': [17, 115], 'were': [18, 36, 70, 99, 108], 'conducted': [19], 'evaluate': [21], 'the': [22, 44, 55, 140, 148, 155, 162, 170, 175], 'pharmacokinetics': [23], 'of': [24, 147, 154, 174], 'RI': [25, 50, 61, 85, 123, 144, 166, 188], 'adult': [27], 'patients': [28], 'with': [29, 183, 197], 'In': [31, 65, 113, 137, 159], 'study': [32, 66, 138, 160], '1,': [33, 139], 'all': [34, 68], 'subjects': [35, 57, 69], 'stable': [37, 71, 182], 'on': [38, 72], '4': [39, 75], 'mg': [40, 49, 60, 81], 'oral': [41, 73, 149, 156, 171, 205], 'risperidone;': [42], 'subsequently,': [43], 'first': [45], 'subject': [46], 'received': [47, 58, 84], '375': [48, 59], 'for': [51, 62, 94, 143, 165, 194], 'month,': [53], 'and': [54, 82, 133, 152], 'remaining': [56], '3': [63], 'months.': [64, 96], '2,': [67, 161], 'mg,': [76, 78, 87, 89, 92], '6': [77, 95], 'or': [79, 90], '8': [80], 'subsequently': [83], '480': [86], '720': [88], '960': [91], 'respectively,': [93], 'Blood': [97], 'samples': [98], 'collected': [100], 'at': [101], 'prespecified': [102], 'time': [103], 'points.': [104], 'Various': [105], 'pharmacokinetic': [106], 'parameters': [107], 'determined': [109], 'both': [111, 114], 'studies.': [112], 'total': [117], 'active': [118], 'moiety': [119], 'plasma': [120, 201], 'concentrations': [121], 'following': [122], 'increased': [124], 'slowly,': [125], 'reached': [126], 'therapeutic': [127], 'levels': [128], 'within': [129], 'approximately': [130], '2': [131], 'days,': [132], 'remained': [134, 181], 'relatively': [135], 'stable.': [136], 'average': [141], 'concentration': [142, 151, 164, 173], '81.3%': [146], 'trough': [150, 172], '27.5%': [153], 'peak': [157], 'concentration.': [158], 'steady-state': [163], 'comparable': [168], 'corresponding': [176], 'dose.': [177], 'Patient': [178], 'disease': [179], 'status': [180], 'no': [184], 'major': [185], 'safety': [186], 'issues.': [187], 'may': [189], 'represent': [190], 'an': [191], 'alternative': [192], 'schizophrenia': [195], 'treatment': [196], 'a': [198], 'lower': [199], 'peak-to-trough': [200], 'drug': [202], 'ratio': [203], 'than': [204], 'risperidone.': [206]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2791629423', 'counts_by_year': [{'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 4}, {'year': 2021, 'cited_by_count': 3}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 5}], 'updated_date': '2024-12-13T20:22:28.513530', 'created_date': '2018-03-29'}